Brendan O' Farrell,
President,
DCN Diagnostics
Brendan has worked in the rapid diagnostics field for over 20 years in various R&D, Manufacturing and Management capacities. Having gained a Ph.D. in Medical Microbiology from University College Dublin, he began his commercial career in the rapid diagnostics business at Trinity Biotech in Dublin as a development team leader. After immigrating to the US, he became Director of R&D, and later, the Director of Manufacturing at Saliva Diagnostic Systems in Vancouver, WA. Here, he was responsible for the development and manufacturing of a wide range of FDA-regulated medical diagnostic products. Upon moving to California, Brendan became Vice President of Technology Development at BioDot Inc. At BioDot, he was responsible for the engineering and process development groups. He also established The One Step…One Solution (OSOS) Program, which was a successful assay development and consulting division of BioDot’s business. In 2005, Brendan and DCN co-founder, Michael Surmanian, effected a management buyout of the OSOS business and transitioned it into DCN.
|
|
|